2013 ACC/AHA guideline on the treatment of blood cholesterol to reduce atherosclerotic cardiovascular risk in adults: A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines Public Deposited

Downloadable Content

Download PDF
Creator
  • Goldberg, Anne C.
  • Robinson, Jennifer G.
  • Shero, Susan T.
  • Lichtenstein, Alice H.
  • Blum, Conrad B.
  • Smith, Sidney C., Jr.
    • Affiliation: School of Medicine, Division of Cardiology, Department of Medicine
  • Lloyd-Jones, Donald M.
  • Levy, Daniel
  • Gordon, David
  • Wilson, Peter W. F.
  • Eckel, Robert H.
  • Bairey Merz, C. Noel
  • Stone, Neil J.
  • Schwartz, J. Sanford
  • Watson, Karol
  • McBride, Patrick
Abstract
  • The Expert Panel was charged with using data from randomized controlled trials (RCTs) and systematic reviews and meta-analyses of RCTs to update the clinical practice recommendations for the treatment of blood cholesterol levels to reduce ASCVD risk. For this guideline, ASCVD includes coronary heart disease (CHD), stroke, and peripheral arterial disease, all of presumed atherosclerotic origin. These recommendations are intended to provide a strong, evidence-based foundation for the treatment of cholesterol for the primary and secondary prevention of ASCVD in women and men.
Date of publication
Keyword
Identifier
  • 2-s2.0-84897970506
  • doi:10.1161/01.cir.0000437738.63853.7a
Related resource URL
Resource type
  • Journal Item
Rights statement
  • In Copyright
Journal title
  • Circulation
Journal volume
  • 129
Journal issue
  • 25 SUPPL. 1
Page start
  • S1
Page end
  • S45
Language
  • English
Version
  • Postprint
ISSN
  • ‎0009-7322
Parents:

This work has no parents.

Items